"Sophisticated technology. Innovative treatments. Dedicated specialists. Walk into Mitchell Memorial Cancer Center and you've entered more than just a building. Now you've become part of our comprehensive approach to treating cancer."

During the past decade, Owensboro Health Mitchell Memorial Cancer Center conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 17 clinical trials were completed, i.e. on average, 121.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 12 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Owensboro Health Mitchell Memorial Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Radiation Therapy Oncology Group" with 4 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Owensboro Health Mitchell Memorial Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Canadian Cancer Trials Group" with 3 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Owensboro Health Mitchell Memorial Cancer Center" are "Lung Cancer" (3 trials), "Stage II Breast Cancer" (3 trials), "Stage IIIB Cutaneous Melanoma AJCC v7" (3 trials), "Stage IIIC Cutaneous Melanoma AJCC v7" (3 trials) and "Stage IV Cutaneous Melanoma AJCC v6 and v7" (3 trials). Many other conditions were trialed in "Owensboro Health Mitchell Memorial Cancer Center" in a lesser frequency.

Most popular intervention types in "Owensboro Health Mitchell Memorial Cancer Center" are "Drug" (23 trials), "Other" (19 trials), "Biological" (11 trials), "Radiation" (10 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (9 trials), "Quality-of-Life Assessment" (8 trials), "Docetaxel" (5 trials), "Bevacizumab" (4 trials) and "Gemcitabine Hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Owensboro Health Mitchell Memorial Cancer Center" are 21 trials for "All" genders, 11 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Owensboro Health Mitchell Memorial Cancer Center". undefined are not yet recruiting, 4 are recruiting, 24 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Owensboro Health Mitchell Memorial Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Owensboro Health Mitchell Memorial Cancer Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".